Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the barriers to optimal survivorship care for people living with Cancer in NSW.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Cervical cancer burden and elimination readiness in the US-affiliated Pacific Islands: A structured narrative review.

Cancer epidemiology·2026
Same author

Effectiveness, Quality of Life and Durability of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Real-World Evidence from the PRIMMA Study.

Dermatology and therapy·2026
Same author

Evaluating Prognostic Factors for Sex Differences in Lung Cancer Survival: A Retrospective Analysis of Real-World Data in Australia.

Clinical lung cancer·2026
Same author

Trajectories of health-related quality of life after cancer diagnosis in a cohort of Australian women: a longitudinal study.

Health and quality of life outcomes·2026
Same author

Cardiovascular Disease Mortality Patterns Among People With Cancer in New South Wales, Australia: A Population-Wide Data Linkage Study.

Cancer medicine·2026

Related Experiment Video

Updated: May 15, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

[Psoriasis and cardiovascular risk factors].

Roy Tal1, Lev Pavlovsky, Michael David

  • 1Dermatology Department, Rabin Medical Center, Petah Tikva, Israel.

Harefuah
|January 16, 2013
PubMed
Summary

Psoriasis, a chronic inflammatory skin condition, is increasingly linked to cardiovascular disease risk factors. This review highlights research, particularly from Israel, on this important association.

Area of Science:

  • Dermatology
  • Cardiology
  • Epidemiology

Context:

  • Psoriasis is a prevalent chronic inflammatory skin disease with significant patient impact.
  • Growing evidence suggests a connection between psoriasis and cardiovascular disease (CVD).
  • Understanding this link is crucial for comprehensive patient management.

Purpose:

  • To review the current literature on the association between psoriasis and cardiovascular disease risk factors.
  • To emphasize research findings specific to the Israeli population.

Summary:

  • The review synthesizes studies examining the relationship between psoriasis and various cardiovascular risk factors.
  • Key findings indicate a notable comorbidity between psoriasis and conditions like hypertension, dyslipidemia, and diabetes.

Related Experiment Videos

Last Updated: May 15, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

  • Research from Israel contributes significantly to understanding these associations within a specific demographic.

    • Impact:

    • Highlights the need for increased cardiovascular risk screening in psoriasis patients.
    • Informs clinical practice regarding the holistic management of individuals with psoriasis.
    • Underscores the importance of multidisciplinary approaches in addressing the comorbidities of psoriasis.